Company / Gross Profit
ENDRA Life Sciences Inc. Gross Profit History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
-
FY2020
5-year range
$0 / $178.8K
FY2017-FY2020
Trend
-100.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $178,840 to $0 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, gross profit decreased 100.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0 | -100.0% |
| FY2019 | $6.2K | -96.5% |
| FY2018 | $178.8K | +0.0% |
| FY2017 | $178.8K | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026